メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
永井 拓
精神神経・神経行動薬理学研究部門
h-index
6956
被引用数
45
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1998 …
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(169)
類似のプロファイル
(6)
フィンガープリント
Taku Nagaiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Neuroscience
Amyloid
28%
Aspartic Acid
12%
Astrocyte
30%
Behavior (Neuroscience)
60%
Brain-Derived Neurotrophic Factor
13%
Cell Signaling
13%
Clozapine
23%
Cognitive Disorders
71%
Cognitive Function
25%
Conditioned Place Preference
13%
Dehydroepiandrosterone Sulfate
18%
Dementia Praecox
100%
Dopamine Receptor D1
18%
Dopamine Release
35%
Dopaminergic
20%
Eicosanoid Receptor
38%
Exon
13%
Extracellular Signal-Regulated Kinases
22%
Fasudil
12%
Fibrinolysin
32%
Glucocorticoid Receptor
12%
Haloperidol
20%
Hippocampus
53%
In Vivo
24%
Kinase
16%
Medium Spiny Neuron
20%
Memory Disorder
45%
Mitogen-Activated Protein Kinase
16%
Morphine
41%
Nerve Cell Differentiation
18%
Neurogenesis
14%
Neuronal Migration
17%
Nucleus Accumbens
57%
Oxidative Stress
16%
Phencyclidine
52%
Polycytidylic Acid
24%
Prefrontal Cortex
62%
Promoter Region
12%
Proteinase Activated Receptor 1
15%
Receptor Agonists
13%
Receptor Antagonist
20%
Recognition Memory
35%
Reelin
22%
Rho Kinase
19%
Silibinin
16%
Social Behavior
15%
Striatum
31%
Synaptic Plasticity
23%
Tissue Plasminogen Activator
50%
Working Memory
17%
Pharmacology, Toxicology and Pharmaceutical Science
Allergic Reaction
5%
Amnesia
6%
Amyloid
5%
Amyotrophic Lateral Sclerosis
5%
Bioflavonoid
11%
Broxuridine
8%
Butyrate
6%
Cholinergic Receptor Stimulating Agent
5%
Cisplatin
6%
Clozapine
7%
Cognitive Defect
25%
Creatinine
16%
Cyclic AMP Dependent Protein Kinase
5%
Cytokine
5%
Dehydroepiandrosterone Sulfate
16%
Disease
6%
Dopamine 1 Receptor
5%
Dopamine Receptor
5%
Dopamine Receptor D2
6%
Dopamine Receptor Stimulating Agent
8%
Fasudil
8%
Fluorouracil
9%
Histone
5%
Hydrochloric Acid
5%
Knockout Mouse
6%
Memory Disorder
7%
Molecular Target
5%
Monoamine
8%
Morphine
21%
Morphine Addiction
5%
Mouse
67%
Mouse Model
14%
Nedaplatin
11%
Neurosteroid
6%
Nobiletin
11%
P21 Activated Kinase
5%
Pentetrazole
5%
Phencyclidine
17%
Phosphotransferase
9%
Placenta Extract
5%
Plasmin
9%
Potassium Channel KCNQ2
5%
Protein Kinases
5%
Receptor
7%
Rho Kinase
9%
Rho Kinase Inhibitor
6%
Serotonin 1A Receptor
5%
Stomach Cancer
5%
Tissue Plasminogen Activator
16%
Uterine Cervix Cancer
5%
Keyphrases
3xTg-AD
5%
Abuse-deterrent Opioid Formulation
5%
Addictive Drugs
6%
Astrocyte-conditioned Medium
6%
AUTS2
11%
Baclofen
6%
Citrus Flavonoids
11%
Clozapine
7%
Cognitive Impairment
9%
Control Decision-making
5%
D1 Receptor
6%
Depolarization
5%
Dopamine D1 Receptor
8%
Dopamine Release
8%
Drugs of Abuse
8%
Emotional Behavior
9%
Extracellular Signal-regulated Kinase 1/2
12%
Girdin
5%
Matrix metalloproteinase-3 (MMP-3)
5%
Memory Impairment
19%
Methamphetamine
25%
Microinjection
8%
MK-801
9%
N-methyl-D-aspartate Receptor (NMDAR)
7%
Neuronal Homeostasis
5%
Nicotine
17%
Nicotine Reinforcement
5%
Nobiletin
11%
Nucleus Accumbens
10%
Phencyclidine
6%
Phosphorylation
11%
Plasmin
6%
Plasmin System
7%
Prefrontal Cortex
6%
Prepulse Inhibition
6%
Protease-activated Receptor 1 (PAR1)
10%
Rap1
6%
Receptor Agonist
6%
Receptor Regulation
5%
Receptor Signaling
7%
Recognition Memory
13%
Reward Signal
5%
Rewarding Effect
11%
Rotational Motion
5%
Schizophrenia
5%
Silibinin
11%
Steroid Response
5%
Striatum
9%
Tissue Plasminogen Activator (t-PA)
16%
Working Memory
5%
